Patients can receive their injections at the office weekly or be taught self-administration of the treatment
Last month, Eli Lilly, the maker of retatrutide, released top-line results from its late-stage (phase 3) clinical trial named TRIUMPH1
By reducing joint pain and accelerating injury recovery, it enables patients to comfortably maintain the active, exercise-rich lifestyle necessary for shedding pounds
Weight Management: Research focuses on mechanisms underlying weight loss, including effects on satiety and energy expenditure
New study reveals semaglutide outperforms liraglutide in weight loss for obesity, highlighting key factors that contribute to significant weight reduction in patients
Water-assisted liposuction for lipoedema was pioneered early in the 2000s and has been adopted worldwide